D. Sgroi
Science · 2001–2014
A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.
Whom D. Sgroi trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Y. Hochberg (in Evaluation & Benchmarks)
Who trusts D. Sgroi
- K. Guan (in Molecular Biology)
- David M. Sabatini (in Molecular Biology)
- M. Laplante (in Molecular Biology)
- Duojia Pan (in Cell Biology)
Papers from D. Sgroi's perspective
Ordered by how strongly the researchers D. Sgroi trusts endorse each paper. Same corpus, a different order for every researcher.
- Inaugural Article: The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
- A comparison of normalization methods for high density oligonucleotide array data based on variance and bias (Bioinform.)
- Gene Ontology: tool for the unification of biology
- Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. (Molecules and Cells)
- Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. (Genes & Development)
- From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
- Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. (Current Biology)
- Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. (Genes & Development)
- Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression (Oncogene)
- Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 (Nature Cell Biology)
Their papers
- Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon (2006) — 969 citations
- Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. (2008) — 755 citations
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition (2013) — 2,310 citations
- Sequence analysis of mutations and translocations across breast cancer subtypes (2012) — 1,207 citations
- Gene expression profiles of human breast cancer progression (2003) — 886 citations
- Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility (2014) — 887 citations
- BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. (2001) — 710 citations
- Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. (2010) — 947 citations
- Gene expression profiling of the tumor microenvironment during breast cancer progression (2009) — 629 citations
- Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials. (2005) — 623 citations
- A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. (2004) — 983 citations